Alnylam Pharmaceuticals sees $1.6B to $1.725B TTR revenue in 2025 driven by AMVUTTRA expansion
Q4 2024 Management View CEO Yvonne Greenstreet highlighted 2024 as a strong year with $1.6 billion in net product revenues, achieving the upper end of the revised guidance. She emphasized the positive ...
Frontiers23h
Advanced Strategies for Energy Management and Stability in Smart Microgrids
The global push for sustainable energy systems has accelerated the adoption of renewable energy sources and decentralized energy networks. Microgrids have ...